Your shopping cart is currently empty

SK-216, a specific PAI-1 inhibitor, reduces tumor angiogenesis and inhibits VEGF-induced migration and tube formation of human umbilical vein endothelial cells in vitro. This compound also alleviates bleomycin-induced pulmonary fibrosis in mice.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $30 | - | In Stock | |
| 5 mg | $60 | - | In Stock | |
| 10 mg | $98 | - | In Stock | |
| 25 mg | $193 | - | In Stock |
| Description | SK-216, a specific PAI-1 inhibitor, reduces tumor angiogenesis and inhibits VEGF-induced migration and tube formation of human umbilical vein endothelial cells in vitro. This compound also alleviates bleomycin-induced pulmonary fibrosis in mice. |
| In vitro | Methods: Human osteosarcoma cell line 143B was treated with SK-216 (0-50 μM, hours), and the expression of target proteins was detected by Western blot. Results: SK-216 at concentrations of 25 and 50 μM inhibited PAI-1 expression by 40%, resulting in a significant decrease in the ratio of cell invasion pores to total pores, and was able to inhibit the secretion of MMP-13 in 143B cells. [2] |
| In vivo | Methods: SK-216 (6.6 μg/200 μL, intraperitoneal injection, once every three days) was used to treat a mouse model of spontaneous lung metastasis to examine whether it inhibits the lung metastasis of human osteosarcoma cells. Results: SK-216 inhibited the lung metastasis of human osteosarcoma cells from the primary lesion, but did not inhibit tumor growth. [2] |
| Synonyms | SK216 |
| Molecular Weight | 533.52 |
| Formula | C29H29NNa2O6 |
| Cas No. | 654080-03-2 |
| Smiles | O=C([O-])C(C([O-])=O)CCCCCOC1=CC2=CC=C(C=C2C=C1)C3=NC4=CC(C(C)(C)C)=CC=C4O3.[Na+].[Na+] |
| Relative Density. | 1.31g/cm3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||
| Solubility Information | H2O: 5.38 mg/mL (10.08 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
H2O
| |||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.